One study [46] indicated that LYVE-1 and Prox-1 are molecular markers of lymphangiogenesis in NSCLC and that they can be used as important markers for the evaluation of lymphatic metastasis and prognoses in patients with NSCLC. Here, LYVE1 is linked to non-small cell lung carcinoma.